A detailed history of Opinicus Capital, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Opinicus Capital, Inc. holds 37,917 shares of PFE stock, worth $992,287. This represents 0.88% of its overall portfolio holdings.

Number of Shares
37,917
Previous 42,376 10.52%
Holding current value
$992,287
Previous $1.19 Billion 7.45%
% of portfolio
0.88%
Previous 1.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $123,514 - $139,968
-4,459 Reduced 10.52%
37,917 $1.1 Billion
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $58,173 - $68,168
2,303 Added 5.75%
42,376 $1.19 Billion
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $162,200 - $186,258
6,265 Added 18.53%
40,073 $1.11 Billion
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $883,403 - $1.15 Million
33,808 New
33,808 $973 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Opinicus Capital, Inc. Portfolio

Follow Opinicus Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opinicus Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opinicus Capital, Inc. with notifications on news.